← All organizations

ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd

For profitWebsite ↗

Also known as: ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd | ImmuneOnco Biopharmaceuticals (Shanghai) Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 15, 2025

Timeline

2010s

Jun 1, 2015
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd— Founded

Drugs by trial phase (19 distinct, 20 trials)

Phase 3 (5 own, 0 via acquisition)

Phase 2 (9 own, 0 via acquisition)

Phase 1 (5 own, 0 via acquisition)

Recent trials (22)

NCT07170787Lead sponsorPhase 1/Phase 2Oct 15, 2025
NCT07118085Lead sponsorPhase 1Aug 18, 2025
NCT06788431Lead sponsorPhase 2Feb 19, 2025
NCT06746870Lead sponsorPhase 2Dec 31, 2024
NCT06746870OfficialPhase 2Dec 31, 2024
NCT06647862Lead sponsorPhase 3Oct 24, 2024
NCT06764836Lead sponsorPhase 1Jul 23, 2024
NCT06465446Lead sponsorPhase 3Jun 30, 2024
NCT05985083Lead sponsorPhase 1Aug 18, 2023
NCT05771883Lead sponsorPhase 1/Phase 2May 31, 2023
NCT05780307Lead sponsorPhase 1Mar 23, 2023
NCT05549557Lead sponsorPhase 1Sep 30, 2022
NCT05833984Lead sponsorPhase 1/Phase 2May 17, 2022
NCT05235438Lead sponsorPhase 1Mar 18, 2022
NCT05805956Lead sponsorPhase 1/Phase 2Feb 15, 2022

Details

Founded: Shanghai, CN Jun 1, 2015
Last known activity: Oct 15, 2025